RS Belgrade Lalic NM: Difference between revisions

From Bioblast
No edit summary
No edit summary
Β 
(6 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{O2k-Network Lab
{{O2k-Network Lab
|institution=Clinic for Endocrinology, Diabetes and Metabolic Diseases
|institution=Clinic for Endocrinology, Diabetes and Metabolic DiseasesClinical Center of Serbia
Clinical Center of Serbia
|address=Faculty of Medicine University of BelgradeDr Subotica 13, Belgrade
|address=Faculty of Medicine University of Belgrade
Β 
Dr Subotica 13, Β 
Belgrade
|area code=11000
|area code=11000
|city=Belgrade
|city=Belgrade
|country=Republic of Serbia
|country=Republic of Serbia
|Contact=Lalic Nebojsa M
|Contact=Lalic Nebojsa M
|MiPNetLab=Krako Jakovljevic Nina, Pavlovic Kasja,
|MiPNetLab=Krako Jakovljevic Nina, Pavlovic Kasja, Ivanovic Tijana
|Status=O2k 2016 –
|Status=O2k 2016 –
|info=[[MiPNet15.12 IOC57 Druskininkai LT]]
|info=[[MitoEAGLE_WG4_Matrei_a._Brenner_2019-03| MitoEAGLE 2019 AT]], [[MiP2018/MitoEAGLE Jurmala LV|MitoEAGLE 2018 LV]], [[MitoEAGLE Obergurgl 2017| MitoEAGLE 2017 AT]], [[MiPschool Obergurgl 2017| MiPschool 2017]], [[MitoEAGLE Verona 2016| MitoEAGLE 2016 IT]], [[IOC112]], [[MiPschool London 2015 | MiPschool 2015]], [[MiP2010]], [[MiPNet15.12 IOC57 Druskininkai LT| IOC57]]
}}
}}
== Bioblast alert ==
::::* [[Bioblast alert 2021]] Β» [[Krako Jakovljevic 2021 MitoFit PD]]

Latest revision as of 09:50, 13 June 2022

                



RS Belgrade Lalic NM

Oroboros O2k-Network

O2k-Network
O2k-Network Lab Clinic for Endocrinology, Diabetes and Metabolic DiseasesClinical Center of Serbia
Address Faculty of Medicine University of BelgradeDr Subotica 13, Belgrade, 11000
City Belgrade
State/Prov
Country Republic of Serbia
Weblink
Contact Lalic Nebojsa M
Team Krako Jakovljevic Nina, Pavlovic Kasja, Ivanovic Tijana
Team previous
Status O2k 2016 –
Oroboros Events MitoEAGLE 2019 AT, MitoEAGLE 2018 LV, MitoEAGLE 2017 AT, MiPschool 2017, MitoEAGLE 2016 IT, IOC112, MiPschool 2015, MiP2010, IOC57
Topics


O2k-Publications

 PublishedReference
Pesta 2021 Front Endocrinol (Lausanne)2021Pesta D, Jelenik T, Zaharia OP, Bobrov P, GΓΆrgens S, BΓ³dis K, Karusheva Y, Krako Jakovljevic N, Lalic NM, Markgraf DF, Burkart V, MΓΌssig K, Knebel B, Kotzka J, Eckel J, Strassburger K, Szendroedi J, Roden M (2021) NDUFB6 polymorphism is associated with physical activity-mediated metabolic changes in type 2 diabetes. https://doi.org/10.3389/fendo.2021.693683
Krako Jakovljevic 2021 Int J Mol Sci2021Krako Jakovljevic N, Pavlovic K, Jotic A, Lalic K, Stoiljkovic M, Lukic L, Milicic T, Macesic M, Stanarcic Gajovic J, Lalic NM (2021) Targeting mitochondria in diabetes. Int J Mol Sci 22:6642.

O2k-Abstracts

 PublishedReference
Calabria 2019 MiPschool Coimbra2019
Elisa Calabria
Investigating mitochondrial function in blood cells by high-resolution respirometry: contribution to an interlaboratory study. MitoEAGLE WG4.
Pavlovic 2019 MiP20192019
Barbara Cannon
Effects of therapeutic metformin concentration on mitochondria in muscle cells.
Zujovic 2019 MiP20192019
Tijana Zujovic
Cell membrane permeabilization: digitonin optimization pitfalls.
Krako Jakovljevic 2019 MiP20192019
Nina Krako Jakovljevic
Lower insulin sensitivity differently affects mitochondrial coupling in liver and muscle cells.
Lalic 2109 MiP20192019
Nebojsa Lalic
Pathophysiology of type 2 diabetes and mitochondrial dysfunction: possible therapeutic implications.
Pavlovic 2017 MITOEAGLE Obergurgl2017
Kasja picture.JPG
Establishing cellular model for studying mechanisms of muscle insulin resistance: towards understanding the role of mitochondria.
Krako 2016 Abstract MitoFit Science Camp 20162016Conformational targeting of amyloid Ξ² oligomers inside endoplasmic reticulum rescues mitochondrial deficits in 7PA2 cells.

Bioblast alert

Cookies help us deliver our services. By using our services, you agree to our use of cookies.